HSBC Boosts CVS Health (NYSE:CVS) Price Target to $85.00

CVS Health (NYSE:CVS) had its price objective hoisted by equities research analysts at HSBC from $83.00 to $85.00 in a research report issued to clients and investors on Tuesday,MarketScreener reports. The firm currently has a “hold” rating on the pharmacy operator’s stock. HSBC’s price objective would suggest a potential upside of 3.75% from the stock’s current price.

CVS has been the topic of a number of other research reports. Leerink Partners reiterated an “outperform” rating and set a $98.00 price target on shares of CVS Health in a report on Thursday, March 5th. Piper Sandler decreased their price objective on CVS Health from $101.00 to $99.00 and set an “overweight” rating for the company in a research report on Tuesday, March 31st. Wolfe Research lowered their target price on CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research note on Monday, March 2nd. Sanford C. Bernstein upgraded CVS Health from a “market perform” rating to an “outperform” rating and upped their target price for the company from $91.00 to $94.00 in a report on Thursday, March 12th. Finally, Argus decreased their price target on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Twenty investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $94.61.

CVS Health Stock Down 0.1%

CVS stock opened at $81.93 on Tuesday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The firm has a market capitalization of $105.00 billion, a P/E ratio of 59.36, a P/E/G ratio of 0.86 and a beta of 0.60. CVS Health has a 52-week low of $58.35 and a 52-week high of $85.15. The company’s 50 day simple moving average is $76.32 and its 200-day simple moving average is $77.96.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities research analysts anticipate that CVS Health will post 7.14 EPS for the current year.

Institutional Investors Weigh In On CVS Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd increased its holdings in CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares during the last quarter. Swiss RE Ltd. acquired a new stake in CVS Health in the fourth quarter valued at approximately $26,000. Sankala Group LLC bought a new stake in CVS Health in the fourth quarter worth approximately $28,000. Global Trust Asset Management LLC increased its stake in shares of CVS Health by 344.8% during the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 300 shares during the last quarter. Finally, Mcguire Capital Advisors Inc. bought a new position in shares of CVS Health during the 4th quarter valued at $28,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.